508209-71-0

Basic information

• Product Name: methyl {3-[5-(3-azidopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate
• Synonyms: methyl {3-[5-(3-azidopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate
• CAS NO: 508209-71-0
• Molecular Weight: 655.659
• Mol File: 508209-71-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl {3-[5-(3-azidopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl {3-[5-(3-azidopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate(508209-71-0)
• EPA Substance Registry System: methyl {3-[5-(3-azidopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate(508209-71-0)

Safety Data

• Hazardous Substances Data: 508209-71-0(Hazardous Substances Data)

Upstream product

• 508209-70-9 methyl {3-[5-(3-bromopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate 
• 1878-67-7 3-Bromophenylacetic acid 
• 5720-06-9 2-Methoxyphenylboronic acid 
• 100-66-3 methoxybenzene 
• 150529-73-0 methyl 2-(3-bromophenyl)acetatee 
• 171905-58-1 methyl [3-(2-hydroxyphenyl)phenyl]acetate 
• 171905-89-8 methyl 3-(2-methoxyphenyl)phenylacetate 
• 173204-11-0 methyl 3-<2-<(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)oxy>phenyl>phenylacetate 
• 253280-01-2 C₉H₁₃BO₃ 
• 508209-69-6 methyl {3-[5-(3-bromopropionyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate 
• 4163-65-9 per-O-acetyl-α-D-mannopyranose 

Downstream Products

• 508209-72-1 methyl {3-[5-(3-aminopropyl)-2-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyloxy)phenyl]phenyl}acetate 
• 724700-58-7 {3-[5-(3-aminopropyl)-2-(α-D-mannopyranosyloxy)phenyl]phenyl}acetic acid 

Relevant articles and documents

Synthesis of a Sialyl LewisX mimetic conjugated with DTPA, potential ligand of new contrast agents for medical imaging

The structure of a mimetic of sialyl LewisX, namely 3-[2-(α-D-mannopyranosyloxy)phenyl]phenylacetic acid, was coupled to diethylenetriaminepentaacetic acid (DTPA) via a flexible alkyl spacer and the amide linkage. The overall yield of the eleven-step synthesis starting from 3-bromophenylacetic acid was 4-8%. This new ligand is expected to target inflammation sites through specific interactions with selectins, the adhesion molecules expressed on the vascular endothelium in pathological conditions. In particular, complexation of the DTPA moiety with gadolinium or radionuclides could produce contrast agents for medical imaging. Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002.